Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

The weight-loss drug boom has become one of the internet's biggest scams
Tags Cybersecurity Weight management LILLY DRN
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Novartis AG Social issues LILLY DRN
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Goodrx Holdings Inc Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Health care industry Business News Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Novo Nordisk A/S Economy Nordstrom Inc
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Health care industry Biotech and Pharmaceuticals Business News
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Health care industry Biotech and Pharmaceuticals Amgen Inc
From CNBC.com News
Cramer's Lightning Round: Eli Lilly is a buy
Tags Marvell Technology Inc Markets Stock markets
From CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
Tags Investing Business Bristol/Myers Squibb Co
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Pharmaceuticals Business US: News
From CNBC.com News
‘Two-stocks’ are better than one? Repacking ‘pair trades'
Tags Automobile manufacturing Markets stocks
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Social issues AstraZeneca PLC Healthy Returns
From CNBC.com News
Jim Cramer says CEOs must properly explain the bad news in every quarter
Tags U/S/ Markets Business News Stock Picks
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Pharmaceuticals Breaking news Novo Nordisk A/S
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still fell short
Tags LILLY DRN Health & Science Companies
From CNBC.com News
Jim Cramer's top 10 things to watch in the stock market Wednesday
Tags Danaher Corp Markets Investment strategy
From CNBC.com News
Eli Lilly stock tumbles 10% after missing estimates and slashing profit guidance
Tags Pharmaceuticals Biotechnology Business
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags DR Horton Inc Stock markets PRO: Playbooks
From CNBC.com News
Cramer’s week ahead: Earnings from Alphabet, Meta, Apple, Microsoft and Amazon
Tags Stock markets Starbucks Corp Investment strategy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Health care industry Diabetes Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: 'Wait for a pullback' with Eli Lilly
Tags Stock Picks Business News S&P 500
From CNBC.com News
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Healthy Returns Social issues Health & Science
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Pharmaceuticals Biotechnology US: News
From CNBC.com News
KKM Financial's Essential 40 stock fund is now an ETF
Tags JPMorgan Chase & Co Waste Management Inc Exchange/traded funds
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Health & Science LILLY DRN Health care industry
From CNBC.com News
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
Tags Pharmaceuticals Health & Science Europe Politics
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Biotechnology
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags JPMorgan Chase & Co Constellation Energy Corp Amazon/com Inc
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Stellantis NV Economy Business
From CNBC.com News
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
Tags Manufacturing Health & Science LILLY DRN
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.